^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Olopade OI, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM, Diaz MO (Dec 1992). "Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia". Genomics. 14 (2): 437–43. doi:10.1016/S0888-7543(05)80238-1. PMID1385305.
Savel'ev VI, Zlochevskiĭ ML, Sorokin AV, et al. (1986). "[Cloning and the determination of the nucleotide sequences in 2 genes of human leukocyte interferons]". Antibiot. Med. Biotekhnol. 31 (8): 592–6. PMID3767336.
Mizoguchi J, Pitha PM, Raj NB (1985). "Efficient expression in Escherichia coli of two species of human interferon-alpha and their hybrid molecules". DNA. 4 (3): 221–32. doi:10.1089/dna.1985.4.221. PMID3891272.
Lund B, von Gabain A, Edlund T, et al. (1985). "Differential expression of interferon genes in a substrain of Namalwa cells". J. Interferon Res. 5 (2): 229–38. doi:10.1089/jir.1985.5.229. PMID4008999.
Fuke M, Hendrix LC, Bollon AP (1985). "Pseudogene IFN-alpha L: removal of the stop codon in the signal sequence permits expression of active human interferon". Gene. 32 (1–2): 135–40. doi:10.1016/0378-1119(84)90041-6. PMID6397400.
Hussain M, Tan T, Ni D, et al. (1998). "A new allele of interferon-alpha17 gene encoding IFN-alpha17b is the major variant in human population". J. Interferon Cytokine Res. 18 (7): 469–77. doi:10.1089/jir.1998.18.469. PMID9712362.
Kim JW, Roh JW, Park NH, et al. (2003). "Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism and cervical cancer risk". Cancer Lett. 189 (2): 183–8. doi:10.1016/S0304-3835(02)00548-7. PMID12490311.